NuVasive to Present at Piper Sandler 33rd Annual Virtual Healthcare Conference
NuVasive, a leader in spine technology, announced that CEO J. Christopher Barry will present at the Piper Sandler 33rd Annual Virtual Healthcare Conference. The pre-recorded chat will be available for on-demand viewing starting November 23, 2021, at 9:00 a.m. PT. The webcast and archived recording can be accessed on NuVasive's Investor Relations page. With over $1 billion in net sales and approximately 2,700 employees worldwide, NuVasive focuses on transformative spine surgery solutions and serves a diverse global clientele.
- None.
- None.
SAN DIEGO, Nov. 18, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that NuVasive CEO J. Christopher Barry will virtually present at the Piper Sandler 33rd Annual Virtual Healthcare Conference.
The pre-recorded fireside chat will be available for on-demand viewing beginning Tuesday, November 23, 2021 at 9:00 a.m. PT/ 12:00 p.m. ET. The webcast, as well as an archived recording, will be available on the Investor Relations section of the Company's website at www.nuvasive.com.
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives. The Company's less-invasive, procedurally integrated surgical solutions are designed to deliver reproducible and clinically proven outcomes. The Company's comprehensive procedural portfolio includes surgical access instruments, spinal implants, fixation systems, biologics, software for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative neuromonitoring technology and service offerings. With more than
Forward-Looking Statements
NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons and hospitals, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive's products, the Company's ability to adequately manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nuvasive-to-present-at-piper-sandler-33rd-annual-virtual-healthcare-conference-301427313.html
SOURCE NuVasive, Inc.
FAQ
When will NuVasive CEO present at the Piper Sandler Healthcare Conference?
How can I view NuVasive's presentation from the Piper Sandler Conference?
What is NuVasive known for in the healthcare industry?
What are NuVasive's recent financial figures?
What is the focus of NuVasive's products?
